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1. Introduction
In-hospital mortality rates after hepatectomy for HCC have been greatly improved due to
advances in surgical techniques and perioperative management [1-4]. However, relatively
high morbidity rates remain problematic, and bile leakage and organ/space surgical site in‐
fection (SSI) are still common causes of major morbidity after hepatectomy for HCC [5-13].
Various types of hepatectomy in many centres have recently been performed based on the
degree of hepatic functional reserve and the location of the HCC. Anatomic hepatectomy for
HCC, including subsegmentectomy, reportedly contributes to the prognosis for patients
with HCC [14-16]. In addition, the rate of repeat hepatectomy for recurrent HCC has recent‐
ly increased from 10% to 31% as the prognosis for patients with HCC has improved [17-22].
In our institution, anatomic and repeat hepatectomies for HCC have been performed aggres‐
sively [12, 16, 22]. We investigated risk factors for bile leakage and organ/space SSI follow‐
ing hepatectomies for HCC in the present series, which included a large number of patients
with a high proportion of anatomic or repeat hepatectomy. Furthermore, causes, manage‐
ment and outcomes of intractable bile leakage and organ/space SSI were investigated and
strategies to reduce major morbidity were considered.
2. Methods
2.1. Patients
Medical records of 359 patients who underwent hepatectomy without biliary reconstruction
for HCC in our department between January 1, 2001 and March 31, 2010 were studied retro‐
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spectively. Patients comprised 292 men and 67 women, with a mean age of 65 years (range,
32-89 years). The aetiology of liver disease was hepatitis C virus in 163 patients, hepatitis B
virus in 122 patients, both hepatitis C virus and hepatitis B virus in 31 patients, and alcoholic
liver disease in 16 patients. Child-Pugh class was A in 332 patients and B in 27 patients. A
total of 296 patients (82.5%) underwent anatomic hepatectomy including subsegmentecto‐
my. Repeat hepatectomy was performed for 59 patients (16.4%). Repeat hepatectomy was
indicated when all tumours detected on preoperative imaging could be resected within the
hepatic functional reserve. When recurrent HCC tumours were 2 cm in maximum diameter
and 3 were present, percutaneous ablation therapies were selected despite the feasibility of
repeat hepatectomy, depending on tumour location in the liver.
2.2. Surgical procedure
Laparotomy was performed through a J incision in 287 patients, a Mercedes incision in 33
patients, a midline incision in 23 patients, and a thoraco-abdominal incision in 16 patients.
Preoperative cholangiography was not usually performed. Intraoperative ultrasonography
was performed to determine the extent of HCC and the line of parenchymal transection. Pa‐
renchymal transection was performed using an ultrasonic dissector (Sonop 5000; Aloka, To‐
kyo, Japan) combined with bipolar electrocautery. Glisson’s pedicles in livers dissected by
the ultrasonic dissector were ligated and small pedicles were resected using metallic surgi‐
cal clips. For hemihepatectomies or extended operations, hilar dissection was performed to
divide the ipsilateral branches of the hepatic artery and portal vein. The hepatic duct was
exposed inside the liver during parenchymal transection and was ligated or oversewn using
fine non-absorbable sutures. Parenchymal transection in hemihepatectomy or extended op‐
erations was performed largely without occlusion of vascular inflow. For segmentectomies
or subsegmentectomies, Glisson’s pedicle was transected at the hepatic hilus and an inter‐
mittent Pringle manoeuvre was applied during parenchymal transection.
Intraoperative cholangiography was undertaken for selected patients when the integrity of
the bile duct was in doubt. A bile leakage test using a cholangiography catheter was also
performed for selected patients when many Glisson’s pedicles were exposed in the plane of
hepatic resection. In principle, two abdominal drainage tubes were systematically posi‐
tioned and the method of placing the drainage tubes was changed according to the type of
hepatectomy. In hemihepatectomy, one drainage tube was placed on the cut surface of the
liver and another was positioned at the Winslow hiatus. In subsegmentectomy and segmen‐
tectomy, one drainage tube was placed on the cut surface of the liver and another was posi‐
tioned in the right subphrenic space. From 2001 to 2005, an open drainage system was
employed using 12-mm silicone Penrose drains (Kaneka, Osaka, Japan). From 2006 to 2010,
a closed drainage system was used with 24-Fr BLAKE silicone drains (Johnson & Johnson,
Somerville, NJ, USA). Drains were removed when the drainage was serous and contained
no bile, usually around postoperative day (POD) 5.
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2.3. Definition of bile leakage
Postoperative bile leakage was defined as the drainage of macroscopic bile from surgical
drains for more than 7 days after surgery. Major bile leakage was defined as macroscopic bile
discharge >100 ml/day that did not decrease from one day to the next. Minor bile leakage was
defined as bile leakage that did not fulfil the definition for major bile leakage. Intractable bile
leakage was defined as bile leakage requiring endoscopic retrograde biliary drainage (ERBD)
or percutaneous transhepatic biliary drainage (PTBD) during postoperative management.
2.4. Definition of SSIs
SSIs were defined according to the National Infections Surveillance system [23]. Using these
criteria, SSIs are classified as either incisional (superficial or deep) or organ/space. Criteria
for superficial incisional SSI included infection occurring at the incision site within 30 days
after surgery that involved only the skin and subcutaneous tissue and at least one of the fol‐
lowing: 1) pus discharge from the incision; 2) bacteria isolated from a sample culture from
the superficial incision; 3) localized pain, tenderness, swelling, redness, or heat; and 4)
wound dehiscence. Criteria for deep incisional SSI included infection of the fascia or muscle
related to the surgical procedure occurring within 30 days after surgery and at least one of
the following: 1) pus discharge from the deep incision; 2) spontaneous dehiscence of the in‐
cision; or 3) deliberate opening of the incision when the patient displayed the previously de‐
scribed signs and symptoms of infection. The definition of organ/space SSI was based on
postoperative findings of at least one of the following: 1) purulent drainage from a drain
without macroscopic bile discharge; or 2) intra-abdominal collection of purulent fluid con‐
firmed at the time of reoperation or percutaneous drainage. If intra-abdominal collection at
the time of reoperation or percutaneous drainage contained macroscopic bile discharge, bile
leakage was considered present. If purulent fluid was drained first and macroscopic bile
leakage subsequently became apparent, this was defined as bile leakage. In contrast, if
drainage of purulent fluid was still observed after the cessation of macroscopic bile leakage,
this was defined as organ/space SSI.
2.5. Antimicrobial prophylaxis
Prophylactic antibiotics regimens were as follows. With initial hepatectomy, a first-genera‐
tion cephalosporin was injected intravenously within 30 min prior to skin incision. In pa‐
tients who underwent operations lasting longer than 3 h, additional antimicrobial agents
were injected intravenously every 3 h, as recommended by the Center for Disease Control
guidelines [23]. These agents were also administered up to POD 2. In repeat hepatectomy,
second-generation cephalosporin was injected intravenously in the same manner as in the
initial hepatectomy and continued until POD 3.
2.6. Intervention for methicillin-resistant Staphylococcus aureus (MRSA)
With the exception of two emergency cases, all  patients underwent preoperative evalua‐
tion for MRSA, including nasal culture. As a result,  9 of the 359 patients (2.5%) showed
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colonisation with MRSA on admission to our institution. In those 9 patients with detec‐
tion  of  MRSA  colonisation  from  preoperative  nasal  cultures,  decolonisation  was  per‐
formed  using  intranasal  mupirocin  therapy  (administered  twice  daily  for  3-5  days
preoperatively). Prophylactic intravenous infusion of vancomycin was not applied in the 9
patients with intranasal MRSA colonisation.
2.7. Analysis of risk factors for bile leakage and SSIs
Patient demographics, operative and tumour factors, and preoperative liver function were
evaluated to determine impacts on the occurrence of bile leakage and organ/space SSI. Pre‐
operative factors included patient age, sex, aetiology of liver disease, Child-Pugh classifica‐
tion, indocyanine green dye retention rate at 15 min (ICG-R15), serum albumin, history of
diabetes mellitus, previous radiofrequency ablation (RFA) and previous transarterial che‐
moembolisation (TACE). The cut-off level for ICG-R15 was set at 20%, because ICG-R15
<20% has been reported as the safe range for bisegmentectomy [3,5,9]. Surgical factors were
evaluated for the type of skin incision, type of hepatectomy, number of hepatectomies,
blood loss, operative time, blood transfusion, and method of abdominal drainage. With re‐
gard to the type of hepatectomy, anterior segmentectomies and medial (S4) segmentecto‐
mies were sub-grouped for analysis. The cut-off point for operative time was determined by
an analysis of the receiver operating characteristics curve for bile leakage. The optimal cut-
off for operative time was 306 min; sensitivity and specificity were 0.696 and 0.728, respec‐
tively. We thus set 300 min as the cut-off level for operative time. Tumour factors included
the number of HCC lesions and the maximum diameter of HCC. Cut-off level for HCC di‐
ameter was determined according to results from previous reports that analysed risk factors
for morbidity after hepatectomy for HCC [3,5,9,12].
2.8. Investigation of intractable bile leakage
Management and outcomes were investigated for 46 patients with postoperative bile leakage.
Indications for ERBD to treat postoperative bile leakage were based on postoperative findings
of at least one of the following: 1) amount of macroscopic bile discharge from surgical drains
>200 ml/day at 2 weeks after surgery; 2) amount of macroscopic bile discharge from surgical
drains >100 ml/day at 4 weeks after surgery; or 3) macroscopic bile discharge from surgical
drains still continuing at 6 weeks after surgery. PTBD was indicated when postoperative chol‐
angiography and biliary drainage by ERBD were considered impractical. Intractable bile leak‐
age necessitating ERBD or PTBD was encountered in 8 patients. The operative procedure,
number of hepatectomies, timing of biliary procedures, sites of bile leakage and possible caus‐
es of bile leakage were evaluated in these 8 patients with intractable bile leakage.
2.9. Investigation of characteristics in organ/space SSI
Organ/space SSI was classified according to the modified Clavien system [24]: grade I, minor
risk events not requiring special treatment; grade II, potentially life-threatening complications
requiring pharmacological treatment; grade III, complications requiring surgical, endoscopic
or radiological intervention, either with (III-b) or without (III-a) general anaesthesia; grade IV,
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life-threatening complications involving dysfunction of one (IV-a) or multiple (IV-b) major or‐
gans; and grade V, complications resulting in the death of the patient. Management and out‐
comes were investigated for 31 patients with organ/space SSI.  In addition,  the causative
bacterium was identified for both incisional and organ/space SSIs. Furthermore, pre- and in‐
traoperative  parameters,  causative  bacteria  and  hospitalisation  were  compared  between
groups classified by the number of hepatectomies in patients with organ/space SSI.
2.10. Statistical analysis
Operative time, blood loss and postoperative hospital stay are presented as mean ± standard
error of the mean. Differences in qualitative variables were assessed using Fisher's exact test or
the 2 test, while differences in quantitative variables were analysed using the Mann-Whitney
test. Uni- and multivariate logistic regression analyses were used to identify risk factors for bile
leakage and organ/space SSI based on the 18 above-mentioned clinical factors. Relative risk
was described by the estimated odds ratio (OR) with a 95% confidence interval. Two-sided P-
values were computed and an effect was considered significant at the level of P 0.05. All statis‐
tical analyses were performed using SPSS II statistical software (SPSS, Tokyo, Japan).
3. Results
3.1. Risk factors for bile leakage (Tables 1, 3)
Univariate logistic regression analysis revealed several factors associated with increased risk
of developing bile leakage. Repeat hepatectomy influenced the risk of developing bile leak‐
age, with an OR of 3.78 compared to the initial hepatectomy. In contrast, neither previous
RFA nor TACE had any significant impact on the occurrence of bile leakage. Operative time
300 min was associated with increased risk (OR, 5.32; P< 0.001), as was blood loss 2 000 ml
(OR, 4.12; P< 0.001). Multivariate analysis regarding bile leakage confirmed operative time
300 min as an independent risk factor.
Table 1. Univariate analysis of risk factors for bile leakage.
3.2. Risk factors for SSIs (Tables 2, 3)
SSIs developed in 14.5% of patients (n=52), and 3 patients showed both incisional and organ/
space SSIs. Univariate logistic regression analysis revealed several factors associated with
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increased risk of developing SSIs. Repeat hepatectomy influenced the risk of developing
SSIs, with an OR of 8.27 for initial hepatectomy. Operative time 300 min was associated with
increased risk (OR, 4.46; P<0.001). The presence of blood transfusion influenced the risk of
developing SSIs. Presence of bile leakage was associated with increased risk of SSIs (OR,
6.40; P=0.002). Multivariate analysis regarding SSIs confirmed both repeat hepatectomy and
operative time 300 min as independent risk factors.
3.3. Risk factor for incisional SSI (Tables 2, 3)
Incidence of incisional SSI was 6.7% (n=24). Univariate logistic regression analysis revealed
that the presence of blood transfusion was associated with increased risk of developing inci‐
sional SSI. Type of skin incision classified according to the presence or absence of transverse
incision showed no significant influence on the occurrence of incisional SSI in this series.
Multivariate analysis regarding incisional SSI confirmed the presence of blood transfusion
as an independent risk factor.
3.4. Risk factors for organ/space SSI (Tables 2, 3)
Organ/space SSI developed in 8.6% of patients (n = 31). Univariate logistic regression analy‐
sis revealed several factors associated with increased risk of developing organ/space SSI. Re‐
peat hepatectomy influenced the risk of developing organ/space SSI, with an OR of 4.29
compared to initial hepatectomy. In contrast, neither previous RFA nor TACE exerted any
significant impact on occurrence of organ/space SSI.
Table 2. Univariate analysis of risk factors for SSIs.
The method of abdominal drainage (open Penrose drains or closed suction drains) showed
no significant influence. Operative time 300 min was associated with increased risk of or‐
gan/space SSI (OR, 2.99; P< 0.001). Presence of bile leakage was likewise associated with in‐
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creased risk (OR, 3.16; P = 0.01). Blood loss 2 000 ml was associated with increased risk (OR,
2.63; P< 0.001). Multivariate analysis confirmed both repeat hepatectomies and presence of
bile leakage as independent risk factors for organ/space SSI.
Table 3. Multivariate analysis of risk factors for bile leakage and SSIs.
3.5. Management and outcomes of bile leakage (Figure 1)
Management and outcomes of the 46 patients with bile leakage are shown in Figure 1.
Figure 1. Medical management and outcomes for patients with postoperative bile leakage.
Minor bile leakage in 30 patients (65%) was controllable and cured by conservative therapies
comprising drainage alone in 23 patients and drainage with irrigation in 7 patients. Sixteen pa‐
tients (35%) showed complications of major bile leakage. In 8 of these patients, the major bile
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leakage was treated using drainage with irrigation. One patient died due to subsequent in‐
tractable ascites and liver failure during drainage with irrigation, while the other 7 patients
healed. The remaining 8 patients with major bile leakage needed either ERBD or PTBD.
3.6. Characteristics of 8 patients with intractable bile leakage (Table 4)
We investigated the characteristics of the 8 patients who needed either ERBD or PTBD for bile
leakage. High-risk surgical procedures were performed in most of these cases and repeat hepa‐
tectomy was performed in 6 of the 8 patients. The median timing of biliary procedures was
POD 21.5 (range, POD 2-45). Bile leakage sites identified on postoperative cholangiography in‐
cluded the hepatic duct in 2 patients and the raw surface of the liver in 6 patients. Possible caus‐
es of bile leakage as assessed by postoperative cholangiography were as follows: stricture of
the hepatic duct that existed preoperatively, possibly due to previous treatments for HCC in 4
patients (2 patients due to previous hepatectomies, 1 patient due to previous TACE, 1 patient
due to previous RFA), stricture of the hepato-jejunostomy from previous pancreatoduodenec‐
tomy in 1 patient, dyskinesis of the papilla of Vater in 1 patient and intraoperative injury of the
left hepatic duct related to repeat hepatectomy in 2 patients. Three of these 8 patients subse‐
quently showed complications of intractable ascites. In 2 patients, both bile leakage and in‐
tractable ascites were cured without intra-abdominal septic complications. The other patient
with stricture and injury of the left hepatic duct caused by a previous RFA died due to intracta‐
ble ascites, uncontrollable biliary infection and liver failure. Bile leakage in the other 5 patients
healed after either ERBD or PTBD, with no other major morbidities.
Table 4. Characteristic and management of 8 patients with intractable bile leakage.
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3.7. Management and outcome of organ/space SSI
Organ/space SSI in 31 patients was classified as follows: abscess on the cut surface of the liv‐
er in 26 patients; right subphrenic abscess in 4 patients; and liver abscess in 1 patient. One of
the 31 patients with organ/space SSI was treated by reoperation due to right subphrenic ab‐
scess, but died due to myocardial infarction. Eleven patients needed percutaneous drainage
of organ/space SSI and all of them were cured. Organ/space SSI in 19 patients healed with
irrigation of the pre-existing drain. As a result, 31 patients with organ/space SSI were strati‐
fied according to the modified Clavien system as follows: grade I, 0 patients; II, 13 patients;
III-a, 15 patients; III-b, 2 patients; IV-a, 1 patient; IV-b, 0 patients; and V, 0 patients. No mor‐
tality was associated with organ/space SSI in this series, but the postoperative hospital stay
was significantly longer for patients with organ/space SSI (53 7.2 days) than for patients
without organ/space SSI (27 0.9 days, P = 0.001).
3.8. Bacteria causing incisional and organ/space SSI (Table 5)
Causative bacteria for incisional and organ/space SSI comprised gram-positive cocci in 17
patients (70.8%) and 19 patients (61.3%), and gram-negative rods in 6 patients (25.0%) and 9
patients (29.0%), respectively, indicating similar proportions of gram-positive cocci and
gram-negative rods in both incisional and organ/space SSI. MRSA was the causative bacteria
in 12 of 19 patients with organ/space SSI caused by gram-positive cocci.
Table 5. Causative bacteria of incisional and organ/space SSI.
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3.9. Comparison between initial and repeat hepatectomies in patients with organ/space
SSI (Table 6)
We compared clinical parameters between initial and repeat hepatectomies in patients with
organ/space SSI (Table 6). HCC diameter was significantly larger in patients with organ/
space SSI who underwent initial hepatectomy than in patients who underwent repeat hepa‐
tectomy. No significant differences were seen between groups in any other preoperative pa‐
rameters, including patient demographics and preoperative liver function. No significant
differences were identified between groups in operative parameters, including blood loss,
operative time and blood transfusion. Rates of bile leakage were similar between groups. In
contrast, in terms of bacteria causing organ/space SSI, detection of MRSA was significantly
more frequent in the repeat hepatectomy group than in the initial group.
Table 6. Comparison between initial nad repeat hepatectomies in patients with organ/space SSI.
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4. Discussion
In-hospital mortality rates after hepatectomy for HCC have been greatly improved due to
advances in surgical techniques and perioperative management [1-4]. However, relatively
high morbidity rates  remain problematic.  The overall  morbidity rates  after  hepatectomy
for liver tumors have been reported to be 22.6 – 47.7%, and bile leakage and organ/space
surgical site infection (SSI) are still common causes of major morbidity after hepatectomy
for  HCC [5-13].  Various  types  of  hepatectomy in  many centres  have recently  been per‐
formed based on the degree of hepatic functional reserve and the location of the HCC. In
addition,  the rate of  repeat  hepatectomy for recurrent  HCC has recently increased from
10% to 31% as the prognosis for patients with HCC has improved [17-22]. The characteris‐
tic of our study is that this series consisted of a large number and percentage of both ana‐
tomic and repeat hepatectomies for HCC.
Rates of bile leakage after hepatectomy for liver tumours and benign lesions have been re‐
ported as 3.6%-12.0%, varying widely among different studies [6, 7, 11, 12, 25-30]. However,
no standardised definition of bile leakage after hepatectomy has been established. In previ‐
ous reports [6, 8, 11, 13, 30], the definition based on the drainage of macroscopic bile has
been adopted. Several studies has proposed the definition on quantitative basis using the bi‐
lirubin concentration within the drain [26, 28], but these cut-off values varied. Currently, the
International Study Group of Liver Surgery has proposed a consensus definition of bile leak‐
age based on the postoperative course of bilirubin concentration in serum and drainage flu‐
id [31]. Application of a uniform definition of bile leakage is indispensable to enabling
standardised comparison of the results of different clinical reports and to facilitating objec‐
tive evaluation of therapeutic modalities in the field of hepatectomies.
In the present study, prolonged operative time was identified as an independent risk factor
for bile leakage and the type of hepatectomy had no significant impact on the rate of bile
leakage. Several groups have reported that hepatectomies in which the cut surface exposed
the major Glisson’s sheath (i.e., central bisegmentectomy, S4 segmentectomy, and S8 subseg‐
mentectomy) were independent risk factors for bile leakage [8, 28-30]. However, our results
indicate that the standard types of hepatectomy were not risk factors for bile leakage, even if
a wide cut surface with an exposed major Glisson’s sheath was necessary, when assessment
of liver function was appropriate and surgical procedures were performed carefully during
transection of the liver parenchyma. We assume that the prolongation of operative time in
this study was related to the extended duration of liver parenchymal transection and/or re‐
section for severe intra-abdominal adhesions around the liver.
Our results revealed latent stricture of the biliary anatomy and intraoperative injury of the
hepatic duct related to repeat hepatectomy as the main causes of intractable bile leakage re‐
quiring invasive treatment. Preoperative assessment of the biliary anatomy should therefore
be considered for selected patients at high risk of intractable bile leakage. Various measures
could also be applied during surgery to diminish the incidence of major and intractable bile
leakage. First, intraoperative cholangiography should be used, particularly in repeat hepa‐
tectomies and in patients who have been treated with RFA or TACE for HCC located in the
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hepatic hilar region, as the identification of bile duct injury or stricture could allow immedi‐
ate correction. Second, T-tube drainage or trans-cystic duct drainage of the common bile
duct could be indicated in patients needing decompression of the biliary tree, such as pa‐
tients with dyskinesis of the papilla of Vater. Third, particularly in repeat systematised hep‐
atectomies, division of the bile ducts could be performed inside the liver during
parenchymal transection, as this procedure could decrease the risk of injury to the bile ducts
compared to division of the bile ducts at the liver hilum.
In the 1980s and 1990s, organ/space SSI formation after hepatectomy was reported as a fatal
complication causing liver failure and death [32-34]. Although rates of organ/space SSI after
hepatectomy have been reported as 4.7%-25% [35-42], hospital mortality rates caused by or‐
gan/space SSI have declined [7-10, 36, 40]. Several groups have reported high patient age
and presence of diabetes mellitus as independent risk factors for organ/space SSI [36, 39].
However, these variables were not identified as independent risk factors for organ/space SSI
in the present study. Our key result was the identification of repeat hepatectomy as an inde‐
pendent risk factor for organ/space SSI, suggesting that treatment strategies need to be es‐
tablished to reduce the high rate of organ/space SSI after repeat hepatectomy.
Repeat hepatectomy was identified as an independent risk factor for SSI and organ/space
SSI, but previous RFA and TACE were not. Repeat hepatectomy for recurrent HCC is useful
in establishing the good long-term outcomes. Cumulative 5-year survival rates after second
hepatectomy have been reported as 41-69% [17-22]. RFA has recently been confirmed as a
safe and promising therapy for recurrent HCC after hepatectomy. However, sufficient evi‐
dence does not exist to confirm whether RFA actually improves long-term outcomes. Cumu‐
lative 5-year survival rates after RFA for recurrent HCC after hepatectomy have been
reported as 18-51.6% [43-45]. RFA is sometimes ineffective for HCC on the liver surface or
near large vessels. In addition, postoperative adhesions between the remnant liver and gas‐
trointestinal tract may prevent safe percutaneous RFA in patients with recurrent HCC.
In this study, MRSA was detected more frequently in organ/space SSI after repeat hepa‐
tectomy compared with after initial hepatectomy. We assume that most organ/space SSIs
with MRSA after repeat hepatectomy develop as a result of contamination when the sur‐
gical  procedure comes into contact  with intra-abdominal  colonisation or micro-abscesses
of MRSA that had formed after the initial hepatectomy. This assumption might be partial‐
ly supported by our result that the method of abdominal drainage (open or closed) had
no significant influence on the occurrence of organ/space SSI. If this assumption is valid,
preoperative interventions for MRSA, consisting of nasal culture and decolonisation of na‐
sal MRSA, will not greatly reduce the occurrence of organ/space SSI involving MRSA af‐
ter  repeat  hepatectomy.  Walsh  et  al.  recently  reported  that  an  MRSA  intervention
program, in which all patients received intranasal mupirocin and those patients colonised
with MRSA received prophylactic  intravenous infusion of vancomycin,  resulted in near-
complete  and sustained elimination of  MRSA SSIs  after  cardiac  surgery [46].  Regarding
patients  who  undergo  repeat  hepatectomies,  preoperative  detection  of  intra-abdominal
colonisation or micro-abscess containing MRSA is difficult. MRSA intervention programs
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thus need to be improved, particularly for patients who undergo repeat hepatectomies, by
considering the prophylactic intravenous administration of vancomycin.
In conclusion, our results reveal prolonged operative time as an independent risk factor for bile
leakage, and latent stricture of the biliary anatomy and intraoperative injury of the hepatic
duct related to repeat hepatectomy as the main causes of intractable bile leakage necessitating
invasive treatment. Repeat hepatectomy was also identified as an independent risk factor for
organ/space SSI, with MRSA as the main causative bacteria in organ/space SSI after repeat hep‐
atectomy for HCC. Establishment of treatment strategies is thus important for reducing the
high rate of organ/space SSI after repeat hepatectomy. In addition, preoperative assessment of
the biliary anatomy and surgical procedures to decrease the incidence of major bile leakage
should be considered for selected patients at high risk of intractable bile leakage.
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